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Abstract 
The present work explores the antioxidant potential of Helichrysum stoechas (L.) 
Moench phenolic compounds for cosmetic applications involving the following steps: 
chemical characterization, microencapsulation and incorporation into a moisturizer. 
Eighteen different phenolic compounds were identified in flowering aerial parts 
(decoction and hydroalcoholic extract), being 3,5-O-dicaffeoylquinic acid and myricetin 
O-acetylhexoside the most abundant phenolic acid and flavonoid, respectively. 
Comparatively to the decoction form, the hydroalcoholic extract presented both higher 
antioxidant activity and higher phenolic content, being its lyophilized form chosen to 
proceed with microencapsulation studies. Double emulsion/evaporation 
microencapsulation technique was applied to produce polycaprolactone based 
microspheres containing H. stoechas hydroalcoholic extract, which were then 
successfully incorporated into a moisturizer. The results obtained demonstrated the 
antioxidant potential of H. stoechas hydroalcoholic extract and the viability of its 
microencapsulation, thus opening new perspectives for the exploitation of these natural 
phenolic extracts in applications such as the cosmetic industry. 
 
Keywords: Helichrysum stoechas, phenolic compounds, decoction, antioxidant activity, 
microencapsulation, cosmetics 
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1. Introduction 
Natural matrices represent a rich source of biologically active compounds and are an 
example of molecular diversity, with recognized potential for the development of 
cosmetics or cosmeceuticals. Bioactive properties of various plants are connected with 
the presence of phenolic compounds, especially flavonoids (Mishra et al., 2008). The 
biological, pharmacological and medicinal properties of this group of compounds have 
been extensively reviewed (Marchand, 2002) and related to their antioxidant properties 
by preventing UV induced oxygen free radical generation and lipid peroxidation (Kaur 
and Saraf, 2011). 
Cosmetic and cosmeceutical preparations from herbal origin are most popular among 
consumers, as these agents are typically nontoxic and possess strong antioxidant 
activity. Since oxidative stress is one of the major mechanisms for skin aging and 
dermatological disorders, phytochemicals such as phenolic compounds could be useful 
for treating or preventing those conditions (Singh and Agarwal, 2009). 
Ethnobotanical surveys conducted in Northeastern Portugal have highlighted the 
medicinal use of decoctions of Helichrysum stoechas (L.) Moench (shrubby everlasting; 
port. douradinha) for cold, bronchitis and fever (Carvalho, 2010). Moreover, the 
antioxidant potential of extracts of this plant (Carini et al., 2001; Albayrak et al., 2010; 
Barros et al., 2010) could also support the development of cosmetic/cosmeceutical 
products, similarly to some documented examples dealing with the encapsulation of 
various plant extracts and isolated compounds. For example, Harris et al. (2011) studied 
the Ilex paraguariensis extract encapsulation in microspheres and nanoparticles of 
chitosan. This extract presents a high content of phenolic compounds with several 
pharmacological properties including anti-aging activity. In addition, the cutaneous 
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absorption of green tea extract compounds was studied, both in free and 
microencapsulated forms (Wisuitiprot et al., 2011). In what concerns the encapsulation 
of isolated compounds for cosmetic applications, rosmarinic acid (Kim et al., 2010) and 
quercetin (Sacalia and Mezzena, 2009) were studied using polycaprolactone and lipidic 
matrices, respectively. 
Although antioxidant properties of H. stoechas methanol extract (Carini et al., 2001; 
Albayrak et al., 2010; Barros et al., 2010) and phenolic compounds (Lavault and 
Richomme, 2004) have been already investigated, there are no reports neither on the 
hydroalcoholic extract nor on its most used form, decoction. Moreover, to the best of 
our knowledge, microencapsulation of such extracts has never been studied. 
This work aimed to characterize phenolic compounds of the hydroalcoholic extract and 
decoction of H. stoechas flowering aerial parts, and evaluate their antioxidant potential. 
Furthermore, the microencapsulation of the lyophilized hydroalcoholic extract was 
tested by means of water-in-oil-in-water (w/o/w) solvent evaporation technique, a 
widely used method in pharmaceutical and cosmetic applications (Li at al., 2008, Koo et 
al., 2008, Giri et al., 2012). 
 
2. Materials and methods 
 
2.1. Plant material 
Helichrysum stoechas (L.) Moench (Asteraceae) is a perennial species growing to 0.5 
m, in dry, rocky and sandy habitats of the Natural Park of Montesinho territory, Trás-os-
Montes, North-eastern Portugal. The inflorescences and leafy flowering stems of about 
15 cm long were randomly gathered from several specimens in 2009 late spring and 
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early summer, considering the Portuguese folk pharmacopoeia descriptors, the local 
medicinal criteria of use and the species growth patterns. 
Morphological key characters from the Nova Flora de Portugal (Franco, 1994) were 
used for plant identification. Nomenclature follows The Plant List 2013 
(http://www.theplantlist.org/). Voucher specimens are kept in the Escola Superior 
Agrária de Bragança Herbarium (BRESA). The plant material was lyophilized 
(FreeZone 4.5, Labconco, Kansas, USA), reduced to powder (~20 mesh) and kept in the 
best conditions for subsequent use. 
 
2.2. Standards and Reagents 
HPLC-grade acetonitrile was obtained from Merck KgaA (Darmstadt, Germany). 
Formic and acetic acids were purchased from Prolabo (VWR International, France). 
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) was purchased from 
Matreya (Pleasant Gap, PA, USA). 2,2-Diphenyl-1-picrylhydrazyl (DPPH) was 
obtained from Alfa Aesar (Ward Hill, MA, USA). Phenolic compound standards were 
from Extrasynthèse (Genay, France). All other chemicals were of analytical grade and 
purchased from chemical suppliers. Water was treated in a Milli-Q water purification 
system (TGI Pure Water Systems, USA). 
Polycaprolactone diol (Mw 3000) (PCL) was supplied by Solvay Caprolactones (Solvay 
Interox Ltd, United Kingdom) and Tergitol 61E was supplied by Dow Surfactants (The 
Dow Chemical Company, USA). Methylene Chloride (DCM) was purchased from 
Sigma-Aldrich (USA) and Polyvinylalcohol (PVA, trade name Celvol 840) was 
supplied by Celanese Chemicals (USA). 
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2.3. Extraction procedures for phenolic compounds 
A hydroalcoholic extraction was performed using the lyophilized plant material (1 g) 
stirring with 30 mL of methanol:water (80:20, v/v) at 25 ºC at 150 rpm for 1 h and 
filtered through Whatman No. 4 paper. The residue was then extracted with one 
additional 30 mL portion of the hydroalcoholic mixture. The combined extracts were 
evaporated at 35 ºC under reduced pressure (rotary evaporator Büchi R-210, Flawil, 
Switzerland) and then further lyophilized (FreeZone 4.5, Labconco, Kansas, USA)   
A decoction was also prepared from the lyophilized plant material (1 g), by adding 200 
mL of distilled water, heating (heating plate, VELP scientific) and boiling for 5 min. 
The mixture was left to stand for 5 min and then filtered under reduced pressure. The 
obtained decoction was frozen and lyophilized. 
The lyophilized hydroalcoholic extract and decoction were re-dissolved in 
methanol:water (80:20, v/v) and water, respectively (final concentration 2.5 mg/mL), for 
phenolic compounds determination and antioxidant activity evaluation. The final 
solutions were further diluted to different concentrations to be submitted to distinct in 
vitro assays. 
 
2.4. Characterization of phenolic compounds 
The extracts were analysed using a Hewlett-Packard 1100 chromatograph (Agilent 
Technologies) with a quaternary pump and a diode array detector (DAD) coupled to an 
HP Chem Station (rev. A.05.04) data-processing station. A Waters Spherisorb S3 ODS-
2 C18, 3 μm (4.6 mm × 150 mm) column thermostatted at 35 °C was used. The solvents 
used were: (A) 0.1% formic acid in water, (B) acetonitrile. The elution gradient 
established was isocratic 15% for 5 min, 15% B to 20% B over 5 min, 20-25% B over 
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10 min, 25-35% B over 10 min, 35-50% for 10 min, and re-equilibration of the column, 
using a flow rate of 0.5 mL/min. Double online detection was carried out in the DAD 
using 280 nm and 370 nm as preferred wavelengths and in a mass spectrometer (MS) 
connected to HPLC system via the DAD cell outlet. 
MS detection was performed in an API 3200 Qtrap (Applied Biosystems, Darmstadt, 
Germany) equipped with an ESI source and a triple quadrupole-ion trap mass analyzer 
that was controlled by the Analyst 5.1 software. Zero grade air served as the nebulizer 
gas (30 psi) and turbo gas for solvent drying (400 ºC, 40 psi). Nitrogen served as the 
curtain (20 psi) and collision gas (medium). The quadrupols were set at unit resolution. 
The ion spray voltage was set at -4500V in the negative mode. The MS detector was 
programmed for recording in two consecutive modes: Enhanced MS (EMS) and 
enhanced product ion (EPI) analysis. EMS was employed to show full scan spectra, so 
as to obtain an overview of all of the ions in sample. Settings used were: declustering 
potential (DP) -450 V, entrance potential (EP) -6 V, collision energy (CE) -10V. EPI 
mode was performed in order to obtain the fragmentation pattern of the parent ion(s) in 
the previous scan using the following parameters: DP -50 V, EP -6 V, CE -25V, and 
collision energy spread (CES) 0 V. Spectra were recorded in negative ion mode between 
m/z 100 and 1500. 
The phenolic compounds were characterized according to their UV and mass spectra 
and retention times compared with standards when available. For the quantitative 
analysis of phenolic compounds, a 5-level calibration curve was obtained by injection of 
known concentrations (2.5-100 g/mL) of different standard compounds: caffeic acid 
(y=617.91x–691.51; R2=0.9991); chlorogenic acid (y=600.27x–763.62; R2=0.9998); p-
coumaric acid (y=884.6x+184.49; R
2
=0.9999); isorhamnetin 3-O-glucoside 
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(y=262.31x–9.8958; R2=1.000); isorhamnetin 3-O-rutinoside (y=327.42x+313.78; 
R
2
=0.9991); ferulic acid (y=505.97x-64.578; R
2
=0.9999); kaempferol 3-O-glucoside 
(y=190.75x–36.158; R2=1.000); kaempferol 3-O-rutinoside (y=175.02x–43.877; 
R
2
=0.9999); myricetin (y=741.41x-221.6; R
2
=0.999); quercetin 3-O-glucoside 
(y=316.48x–2.9142; R2=1.000); quercetin 3-O-rutinoside (y=222.79x–243.11; 
R
2
=0.9998). The results were expressed in mg per 100 g of dry weight (dw). 
 
2.5. Evaluation of in vitro antioxidant properties 
DPPH radical-scavenging activity was evaluated by using an ELX800 microplate reader 
(Bio-Tek Instruments, Inc; Winooski, VT, USA), and calculated as a percentage of 
DPPH discolouration using the formula: [(ADPPH-AS)/ADPPH]  100, where AS is the 
absorbance of the solution containing the sample at 515 nm, and ADPPH is the 
absorbance of the DPPH solution. Reducing power was evaluated by the capacity to 
convert Fe
3+
 to Fe
2+
, measuring the absorbance at 690 nm in the microplate reader 
mentioned above. Inhibition of -carotene bleaching was evaluated though the -
carotene/linoleate assay; the neutralization of linoleate free radicals avoids -carotene 
bleaching, which is measured by the formula: β-carotene absorbance after 2h of 
assay/initial absorbance)  100. Lipid peroxidation inhibition in porcine (Sus scrofa) 
brain homogenates was evaluated by the decreasing in thiobarbituric acid reactive 
substances (TBARS); the colour intensity of the malondialdehyde-thiobarbituric acid 
(MDA-TBA) was measured by its absorbance at 532 nm; the inhibition ratio (%) was 
calculated using the following formula: [(A - B)/A] × 100%, where A and B were the 
absorbance of the control and the sample solution, respectively (Barros et al., 2010). 
The results were expressed in EC50 values (sample concentration providing 50% of 
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antioxidant activity or 0.5 of absorbance in the reducing power assay). Trolox was used 
as standard. 
 
2.6. Microencapsulation of the hydroalcoholic extract 
Microspheres incorporating lyophilized H. stoechas hydroalcoholic extract were 
prepared by double emulsion/evaporation technique, following the general procedure 
adapted from Giri at al. (2012). Briefly, PCL was used as the matrix material, Tergitol 
61E (HLB 3) as the surfactant for the preparation of the primary w/o (water-in-oil) 
emulsion, and DCM as the oil phase to solubilize PCL. PVA was the protective colloid 
for the stabilization of the secondary o/w (oil-in-water) emulsion. For the preparation of 
the primary emulsion, an aqueous solution was prepared by dissolving 70 mg of the 
lyophilized extract in 4 mL of distilled water under stirring, then filtered and added with 
1.5% (w/w) of Tergitol 61E. The oil phase was prepared by dissolving 800 mg of PCL 
in 20 mL of DMC. The ratio extract/polymer was 70/800 (w/w), which is a value in 
accordance with the ones typically used in literature for microencapsulation purposes. 
The w/o emulsion was prepared by adding the aforementioned aqueous solution to the 
oil phase followed by homogenization at 11000 rpm during 2 minutes using a Cat 
Unidrive X 1000 homogenizer. Finally, the w/o/w emulsion was prepared through the 
addition of the previously prepared w/o emulsion to 200 mL of a PVA aqueous solution 
(1%, w/v) under continuous stirring (400 rpm) during 10 minutes. Microspheres 
consolidation was achieved by DCM evaporation using a Buchi Rotovapor R-114 in 
two steps: 2 hours at 40 ºC and atmospheric pressure followed by one hour under 
reduced pressure (600 mbar). The resulting microspheres were firstly collected by 
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sedimentation, washed twice with distilled water and thereafter recovered through 
filtration. The microspheres were then lyophilized and stored in dark conditions at 4 ºC. 
 
2.7. Microspheres characterization 
Microspheres in solution form were analyzed by optical microscopy (OM) using a 
Nikon Eclipse 50i microscope equipped with a Nikon Digital Sight camera and NIS 
Elements software for data acquisition. OM analysis was applied to access size and 
morphology of the primary and secondary emulsions, as well as of the consolidated 
microspheres. Evidence of successful extract microencapsulation was inspected by 
FTIR analysis. For that purpose, spectra of PCL, hydroalcoholic extract and 
corresponding microspheres were collected on a FTIR Bomen (model MB 104) by 
preparing KBr pellets at a sample concentration of 1% (w/w). Spectra were recorded at 
a resolution of 4 cm
-1
 between 650 and 4000 cm
-1
 and by co-adding 48 scans. 
 
2.8. Microspheres incorporation into a base moisturizer 
Lyophilized microspheres were incorporated in a base formulation prepared by an o/w 
technique. The water phase (WP) comprises 15 mL of water (no thickener was used), 
whereas the oil phase (OP) accounts with 2.0 mL of almond oil added with 0.5 g of 
Olivem 1000 (emulsifier), 0.2 g of Olivem 300 (emollient and co-emulsifier) and 0.25 g 
of Olivax (moisturizer agent). Olivem and Olivax are trademarks of BT Company 
(Milan, Italy). The WP and OP were heated separately to 70-75 ºC until 
homogenization. Thereafter they were left to cool to 40 ºC before adding 100 mg of 
microspheres to the oil phase. Finally the WP was mixed with OP and vigorously stirred 
together. For control purposes, a moisturizer sample without added microspheres was 
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also prepared. Samples with and without microspheres were analyzed by OM and 
compared. 
 
2.9. Statistical analysis  
All the assays were carried out in triplicate and the results are expressed as mean values 
and standard deviation (SD). The results were analyzed using one-way analysis of 
variance (ANOVA) followed by Tukey’s HSD Test with α = 0.05, performed with 
SPSS v. 18.0 program.  
 
3. Results and discussion 
3.1. Phenolic profile of the hydroalcoholic extract and decoction  
The HPLC phenolic profile of a Helichrysum stoechas sample, obtained after 
hydroalcoholic extraction, and recorded at 280 and 370 nm is shown in Figure 1; peak 
characteristics and tentative identities are presented in Table 1. Eighteen compounds 
were detected, nine of which were phenolic acid derivatives. Among them, six 
compounds (peaks 1, 3, 9, 11, 13 and 16) were caffeoylquinic acid derivatives identified 
according to their UV spectra and pseudomolecular ions. Peak 1 ([M-H]
-
 at m/z 353) 
was identified as 3-O-caffeoylquinic acid, yielding the base peak at m/z 191 and the ion 
at m/z 179 with an intensity >73% base peak, characteristic of 3-acylchlorogenic acids 
as reported by Clifford et al. (2003 and 2005). Peak 3 was identified as 5-O-
caffeoylquinic acid by comparison of its UV spectrum ( max 326 nm) and retention time 
with a commercial standard. Peaks 4 and 5 were tentatively identified as 5-O-
coumaroylquinic and 5-O-feruloylquinic acids, respectively, taking into account their 
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pseudomolecular ions, fragmentation patterns and relative intensities similar to 5-O-
caffeoylquinic acid. 
Peaks 9, 11 and 13 ([M-H]
-
 at m/z 515) corresponded to dicaffeoylquinic acids and were 
assigned to 3,5-O- (peaks 9 and 11) and 4,5-O- dicaffeoylquinic acids (peak 13) based 
on their elution order and fragmentation patterns (Clifford et al, 2003; Clifford et al, 
2005). The fragmentation pattern of peaks 9 and 11 was similar to the one previously 
reported by Clifford et al. (2005) for 3,5-O-dicaffeoylquinic acid. MS
2
 base peak was at 
m/z 353, produced by the loss of one of the caffeoyl moieties ([M-H-caffeoyl]
-
), and 
subsequent fragmentation of this ion yielded the same fragments as 5-caffeoylquinic 
acid at m/z 191, 179 and 135, although in this case with a comparatively more intense 
signal at m/z 179 ([caffeic acid-H]
-
, ~70% base peak). These peaks (9 and 11) were 
identified as cis and trans 3,5-O-dicaffeoylquinic acid, respectively, based on the 
elution order described in a previous study (Barros et al., 2012). Peak 13 was assigned 
to 4,5-O-dicaffeoylquinic acid since its fragmentation was identical to that previously 
reported by Clifford et al. (2005). In this case, the signal at m/z 335 was barely 
detectable (<3 % of base peak) and the intense signal at m/z 173 is characteristic for an 
isomer substituted at position 4, which indicated loss of the caffeoyl moiety at position 
5. 
Peak 16 presented a pseudomolecular ion at m/z 529 that yielded fragments at m/z 367 
([O-feruloylquinic acid-H]
-
), 353 ([caffeoylquinic acid-H]
-
, and 179 and 193, 
corresponding to deprotonated caffeic acid and deprotonated ferulic acid, respectively, 
which allowed its identification as a caffeoyl-O-feruloylquinic acid. 
Peak 2 was identified as protocatechuic acid by comparison of its UV spectrum ( max 
260, sh296 nm) and retention time with a commercial standard.  
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The remaining phenolic compounds corresponded to flavonol derivatives (Table 1). 
Myricetin 3-O-glucoside (peak 6) and quercetin 3-O-glucoside (peak 8) were positively 
identified according to their retention, mass and UV-vis characteristics by comparison 
with commercial standards. Pseudomolecular ([M-H]
-
 at m/z 463) and product (m/z at 
301, quercetin) ions of peak 14 allowed its identification as a quercetin hexoside. This 
peak showed max at higher wavelength (370 nm) than quercetin 3-O-glucoside (344 
nm) and similar to quercetin aglycone. According to Mabry et al. (1970), the 
introduction of a glycoside on the hydroxyls at positions 7, 3’ or 4’ should not have 
effect on maximal wavelength or the spectrum shape in relation to the aglycone. Thus, 
peak 14 was tentatively assigned as quercetin 7-O-hexoside.  
Peaks 10 and 12 ([M-H]
-
 at m/z 505) should correspond to quercetin O-acetylhexosides 
according to their pseudomolecular ion and MS
2
 fragment released at m/z 301 
(quercetin; [M-H-42-162]
-
, loss of an acetylhexoside moiety). Similarly, peaks 7, 15 and 
17 were assigned as acetylhexosides of myricetin, isorhamnetin and kaempferol, 
respectively, based on their pseudomolecular and product ions. The bathochromic 
displacement in max observed in peak 7 (366 nm) in relation to myricetin 3-O-glucoside 
(peak 6; 354 nm) might allow assigning it as myricetin 7-O-acetylhexoside.  
Finally, peak 18 presented a pseudomolecular ion [M-H]
-
 at m/z 609, releasing two MS
2
 
fragments ions at m/z 463 ([M-H-146, loss of a p-coumaroyl moiety]
-
) and an m/z 301 
([M-H-162, loss of a hexosyl moiety]
-
), although the loss of 146 mu could also 
correspond to a rhamnosyl residue, the maximum at 315 nm in the UV spectrum of the 
peak pointed to a coumaroyl substituent. Thus, the compound would correspond to a 
quercetin 3-O-[p-coumaroyl]-glucoside. Lavault and Richomme (2004), identified a 
similar compound, quercetin 3-O-[6-trans-p-coumaroyl]-β-D-glucoside 
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(helichrysoside), presenting the same MS and UV spectra, therefore peak 18 was 
assigned to this compound. 
 
trans 3,5-O-Dicaffeoylquinic acid was the most abundant phenolic acid (21.76 and 9.54 
mg/g of extract and decoction, respectively) (Table 2), whereas myricetin 7-O-
acetylhexoside was the most abundant flavonoid found (21.76 and 9.54 mg/g of extract 
and decoction, respectively). The hydroalcoholic extract presented higher concentration 
in phenolic compounds (135.61 mg/g of extract) than the decoction sample (60.37 mg/g 
of decoction). Protocatechuic acid was only found in decoction preparation (Table 2), 
which could be formed as a degradation product of quercetin, due to the high 
temperature applied in this preparation.  
There are some similarities in the phenolic profile identified in H. stoechas flowers from 
Portugal and samples from Italy (Carini et al., 2001) and France (Lavault and 
Richomme, 2004). A sample from Turkey (Albayrak et al., 2010) presented a very 
different profile, being chlorogenic acid the only compound found in common. Lavault 
and Richomme (2004) identified eighteen phenolic compounds (α-pyrones, 
phloroglucinols, phenolic acids, flavonoids, and coumarin), being identified four 
phenolic acids and flavonoids; quercetin-3-O-β-D-glucoside, helichrysoside (quercetin 
3-O-[6-trans-p-coumaroyl]-β-D-glucoside), quercetagetin 7-O- -D-glucoside, 5-
caffeoylquinic acid and 3,5-dicaffeoylquinic acid were also identified in the sample 
studied herein. Carini et al. (2001) identified five phenolic acids and seven flavonoids; 
the phenolic acids profile was similar to the Portuguese sample, whereas for flavonoids 
some differences were found. Those authors identified flavones, such as apigenin and 
naringenin derivatives. Lavault and Richomme (2004) and Carini et al. (2001) did not 
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present quantification data on these compounds. Albayrak et al. (2010) were the only 
authors that presented quantification data, in which the major component present was 
chlorogenic acid, followed by apigenin 7-glucoside. The quantities found by those 
authors were lower than the ones obtained herein.  
 
3.2. In vitro antioxidant properties  
The results obtained in the evaluation of the antioxidant activity of the hydroalcoholic 
extract and decoction of H. stoechas are given in Table 3. The hydroalcoholic extract 
gave higher antioxidant activity (lower EC50 values) in all the in vitro assays (EC50 
values between 79.84 and 36.62 µg/mL) than the decoction preparation (EC50 values 
ranging from 435.20 to 147.03 µg/mL). This is in agreement with the higher phenolic 
compounds concentration (135.61 mg/g) found in the hydroalcoholic extract in 
comparison to the decoction preparation (60.37 mg/g). Regarding radical scavenging 
activity using DPPH assay, the hydroalcoholic extract showed lower activity than 
methanol extracts of H. stoechas from Turkey (EC50 value 7.95 µg/mL, Albayrak et al., 
2010). The methanol extract previously studied by our research group (Barros et al., 
2010) presented higher EC50 values (≤ 520 µg/mL) and, therefore, lower antioxidant 
activity. In our knowledge, no reports are available on the decoction preparation of the 
studied plant.  
 
3.3. Microspheres preparation and incorporation in moisturizers 
PCL based microspheres incorporating lyophilized H. stoechas hydroalcoholic extract 
were prepared by double emulsion/evaporation technique. The encapsulation process 
was monitored by OM analysis by cheeking several key points of the process. Figure 
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2A shows the prepared w/o emulsion evidencing the individualized spherical aqueous 
droplets with an estimated size of 10 µm dispersed in the organic medium (DCM 
containing PCL). Figure 2B and Figure 2C show the final w/o/w emulsion right after 
preparation and after 10 minutes under stirring at 400 rpm, respectively. The obtained 
embryonic microspheres are spherical in shape and it can be noticed the presence of 
droplets in its interior (water droplets containing the extract). Additionally, as expected, 
a size reduction was observed as a consequence of stirring, being the final size of the 
embryonic microspheres estimated to be comprised between 40 and 170 µm. 
Figure 3 shows the microspheres consolidation process. During this stage, the size of 
the obtained microspheres decreased accompanying DCM evaporation. As it can be 
noticed in Figure 3A (micrograph after one hour evaporation at 40 ºC and atmospheric 
pressure) consolidation was negligible, becoming evident only after two hours under 
evaporation in the same conditions (Figure 3B). To ensure total DCM removal, and 
consequently total microspheres consolidation, evaporation proceeded under reduced 
pressure during one additional hour (Figure 3C). Final size of the obtained 
microspheres was estimated to be comprised between 30 and 100 µm. 
FTIR analysis of PCL, lyophilized extract and corresponding microspheres is shown in 
Figure 4. As expected microspheres spectrum was dominated by the presence of PCL (a 
ratio extract/PCL of 70/800 (mg/mg) was used). Nevertheless, comparatively to the 
PCL spectrum, in the microspheres both OH and C=O stretching bands become more 
prominent compared to the CH stretching zone. This could be explained by an effective 
extract incorporation, containing compounds rich in OH and C=O moieties. 
The obtained lyophilized microspheres were easily dispersed in the oil phase, contrary 
to the aqueous phase, where they remain agglomerated. For this reason, the oil phase 
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was chosen as the more adequate vehicle to proceed with microspheres incorporation 
during the moisturizer preparation (an oil-in-water emulsion process). Figure 5 presents 
the images of the produced base moisturizer (Figure 5A), as well as of the moisturizer 
added with the lyophilized microspheres under 100X (Figure 5B) and 400X (Figure 
5C) magnification. As it can be observed, microspheres are clearly visible in the 
moisturizer matrix as individualized particles. 
 
4. Conclusions 
Eighteen different phenolic compounds were identified, being 3,5-O-dicaffeoylquinic 
acid the most abundant phenolic acid and myricetin O-acetylhexoside the most 
abundant flavonoid. Comparatively with the decoction form, the hydroalcoholic extract 
presented the highest antioxidant activity, which can be correlated with its higher 
phenolic compounds content. 
The double emulsion/evaporation microencapsulation technique was successfully 
applied to produce microspheres containing H. stoechas hydroalcoholic extract, which 
opens new avenues for the exploitation of these phenolic extracts in applications such as 
the cosmetic industry. As a preliminary approach microspheres were incorporated into a 
moisturizer. The envisaged methodology comprises its addition to the oil phase 
guarantying a good dispersion, i.e. the absence of agglomerates. 
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Table 1. Retention time (Rt), wavelengths of maximum absorption in the visible region ( max), mass spectral data, tentative identification of phenolic acids and flavonoids in Helichrysum stoechas
P1eak Rt (min) 
max 
 (nm) 
Molecular ion  
[M-H]- (m/z) 
MS2 
(m/z) 
Tentative identification 
1 5.26 326 353 191(100),179(73),173(7),135(55) 3-O-Caffeoylquinic acid 
2 6.14 260,sh296 163 109(100) Protocatechuic acid 
3 8.03 326 353 191(100),179(17),173(17),135(9) 5-O-Caffeoylquinic acid 
4 13.09 310 337 191(100),173(7),163(9),119(3) 5-p-Coumaroylquinic acid 
5 14.81 330 367 191(100),173(10),134(7) 5-O-Feruloylquinic acid 
6 16.23 354 479 317(100) Myricetin 3-O-glucoside 
7 19.67 366 521 317(100) Myricetin 7-O-acetylhexoside 
8 20.64 344 463 301(100) Quercetin 3-O-glucoside 
9 21.78 326 515 353(100),335(13),203(3),191(73),179(69),173(22),161(5),135(22) cis 3,5-O-Dicaffeoylquinic acid 
10 22.19 354 505 301(100) Quercetin O-acetylhexoside 
11 22.22 328 515 353(100),335(5),191(97),179(79),173(9),161(5),135(37) trans 3,5-O-Dicaffeoylquinic acid 
12 24.33 358 505 301(100) Quercetin O-acetylhexoside 
13 24.91 330 515 353(97),335(3),299(4),255(5),203(16),191(30),179(75),173(100),161(4),135(27) 4,5-O-Dicaffeoylquinic acid 
14 27.21 370 463 301(100) Quercetin 7-O-hexoside 
15 27.91 354 519 315(100) Isorhamnetin O-acetylhexoside 
16 28.31 326 529 367(96),353(8),335(6),193(100),191(15),179(6),173(22),134(4) Caffeoyl-O-feruloylquinic acid 
17 29.41 366 489 327(57),285(100) Kaempferol O-acetylhexoside 
18 31.77 315,sh360 609 463(70),301(40) Quercetin 3-O-[p-coumaroyl]-glucoside 
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Table 2. Phenolic compounds quantification (mg/g of extract or decoction) in hydroalcoholic 
extract and decoction of Helichrysum stoechas (mean ± SD).  
Phenolic compounds Hydroalcoholic extract Decoction 
3-O-Caffeoylquinic acid 0.68 ± 0.01 0.99 ± 0.22 
Protocatechuic acid nd 1.14 ± 0.05 
5-O-Caffeoylquinic acid 21.94 ± 0.28 12.12 ± 0.12 
5-p-Coumaroylquinic acid 0.29 ± 0.29 0.26 ± 0.03 
5-O-Feruloylquinic acid 0.55 ± 0.55 0.52 ± 0.06 
Myricetin 3-O-glucoside 9.37 ± 0.08 3.08 ± 0.19 
Myricetin 7-O-acetylhexoside 21.76 ± 0.52 9.54 ± 0.05 
Quecetin 3-O-glucoside 9.28 ± 0.43 3.80 ± 0.19 
cis 3,5-O-Dicaffeoylquinic acid 2.00 ± 0.01 0.79 ± 0.08 
Quercetin O-acetylhexoside 2.63 ± 0.36 1.36 ± 0.06 
trans 3,5-O-Dicaffeoylquinic acid 43.31 ± 0.15 15.65 ± 0.11 
Quercetin 7-O-acetylhexoside 4.49 ± 0.16 2.18 ± 0.01 
4,5-O-Dicaffeoylquinic acid 4.94 ± 0.24 2.97 ± 0.11 
Quercetin 7-O-hexoside 4.93 ± 0.27 1.73 ± 0.05 
Isorhamnetin O-acetylhexoside 0.97 ± 0.04 0.35 ± 0.01 
Caffeoyl-O-feruloylquinic acid 0.45 ± 0.02 0.20 ± 0.02 
Kaempferol O-acetylhexoside 4.61 ± 0.10 2.16 ± 0.02 
Quercetin 3-O-[p-coumaroyl]-glucoside 3.43 ± 0.11 1.51 ± 0.09 
Total phenolic acids 74.16 ± 0.44
a
 34.64 ± 016
b 
 
Total flavonoids 61.45 ± 1.67
a
 25.72 ± 0.02
b
 
Total phenolic compounds 135.61 ± 2.10
a
 60.37 ± 0.14
b
 
In each row different letters mean significant differences (p<0.05).  
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Table 3. Antioxidant activity of Helichrysum stoechas hydroalcoholic extract and decoction 
(mean ± SD). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In each row different letters mean significant differences (p<0.05). 
 
Antioxidant activity Hydroalcoholic extract Decoction 
DPPH scavenging activity 
(EC50, µg/mL) 
36.62 ± 0.39
b
 435.20 ± 2.66
a
 
Reducing power  
(EC50, µg/mL) 
75.14 ± 3.77
b
 187.57 ± 1.98
a
 
β-carotene bleaching inhibition  
(EC50, µg/mL) 
79.84 ± 1.45
b
 171.08 ± 1.71
a
 
TBARS inhibition  
(EC50, µg/mL)  
51.62 ± 1.27
b
 147.03 ± 7.03
a
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Figure 1. HPLC phenolic profile of Helichrysum stoechas hydroalcoholic extract 
recorded at 370 nm (A) and 280 nm (B).  
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Figure 2. Optical microscopy analysis with magnification of 400X of: the w/o emulsion 
(A), w/o/w emulsion immediately after its preparation (B) and after 10 minutes under 
stirring at 400 rpm (C). 
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Figure 3. Microspheres morphology evolution during the solvent evaporation process 
(magnification of 100X): (A) after one hour under evaporation at 40 ºC and atmospheric 
pressure, (B) after two hours under evaporation at 40 ºC and atmospheric pressure, and 
(C) after one additional hour at 40 ºC under reduced pressure. 
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Figure 4. FTIR spectra of polycaprolactone (PCL), lyophilized extract and produced 
microspheres. 
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Figure 5. Microspheres incorporation in a moisturizer. (A) Base moisturizer, (B) 
moisturizer with incorporated microspheres under 100X magnification, and (C) 
moisturizer with incorporated microspheres under 400X magnification. The blank arrow 
puts in evidence the incorporated microspheres structures. 
 
